The Carbetocin Injection Market size is expected to grow at an annual average of 5% during 2021-2027. Carbetocin is a drug used to control postpartum bleeding – bleeding after childbirth. It has a similar action to oxytocin and has a similar action to oxytocin, which induces uterine contractions. According to CIC Edizioni Internazionali, nearly 500,000 women die each year from this potentially preventable cause, and a quarter of these deaths result from bleeding during delivery. Carbetocin was first described in 1987 as a long-acting synthetic oxytocin analogue, 1-deamino-1-monocarbo-(2-O-methyltyrosine)-oxytocin. A single dose of carbetocin was hypothesized to act as a 16-hour intravenous oxytocin infusion. It is about increasing uterine tone and reducing the risk of PPH in elective cesarean section.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Carbetocin Injection Market at: https://www.orionmarketreports.com/request-sample/?id=71545
The following segmentation are covered in this report:
By Application
- Hospitals
- Clinics
- Other
By Type
- Original Drug
- Generic Drug
Company Profile
- Ferring Pharmaceuticals
- Boya Bio
- Hybio Pharmaceutical
- Beacon Pharmaceuticals Ltd.
- Chengdu Shengnuo Biotechnology
- Pfizer
- Tibet Aim Pharm Inc (Aim Pharm)
The report covers the following objectives:
- Proliferation and maturation of trade in the global Carbetocin Injection Market
- The market share of the global Carbetocin Injection Marketsupply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Carbetocin Injection Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Carbetocin Injection Market
Scope of the report
The research study analyses the Carbetocin Injection Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
A full report of Carbetocin Injection Market is available at: https://www.orionmarketreports.com/carbetocin-injection-market/71545/
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by Carbetocin Injection Market Report
- What was the Carbetocin Injection Marketsize in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
- What will be the CAGR of Market during the forecast period (2021-2027)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
- Which manufacturer/vendor/players in the Carbetocin Injection Marketwas the market leader in 2020?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
